Glycemia as risk factor in adult patients admitted at Critical Care Unit of the Hospital de Clínicas
DOI:
https://doi.org/10.18004/Keywords:
Glycemia, risk factor, Critical Care Unit, ParaguayAbstract
Objective: to determine relation between glycemia to the admitions and the evolution of the adult patients admitted to UCIA (Adult Intensive Care Unit) Methods: retrospective cohorte study of patients files admitted in the UCIA, taking sampling of evaluation of the patients according to different levels of glycemia in mg/dL (Gl65, G2 66 to 79, G3 80 to 199 and G4>200). Results: We evaluate 413 patients admitted UCIA, mid age was 48,89±19 years; mean glycemia at admition was 168,8 mg/dL ±93. Were diabetic knowned 11.9% Score Apache II mean 16 (±9), a global mortality in 39.7%; intrahospital infections were found in 22.8%. Mortality in G4 group was of 49.5% versus 35.4% in G3 (RR 1.41 p= 0.008). Intrahospital infections in G4 was 16,2% versus 26,4% in G3 (RR 0.54 p=0.03) Mortality in programmed surgeries in G4 was 30,6% versus 14.7% in G3 (RR 2.07 p=0.04).Had significant tendency in the cardiac surgeries (RR 2.33 p=0.11) and neurological (RR 3.33 p=0,26) bud non-significant in abdominal programmed surgeries G4 12.5% versus 10% in G3 (RR 0,83 p=0.85). Mortality in urgency surgeries was in G4 44,4% versus 44.1% in G3 (RR 1.01 p=0.97). In medical cases, non-surgically treated, mortality was 76,3% in G4 versus 45% in G3 (RR 1.53, p=0.004). Among coronary events, mortality was observed as significantly different comparing G4 vs G3 (42% and 10% respectively, RR 7.13 p=0.001). Regarding hypoglycemia general mortality was higher in those in group G1<65mg/dL the in comparison to groups G2 and G3 (RR 1.80, p=0.05) Conclusions: Greater general mortality was observed among the programmed surgery population and those with acute coronary events, specially in those patients admitted with >200 mg/dL of glycemia.
References
1. Inzucchi S, Rosenstock J. Counterpoint: Inpatient Glucose Management. A premature call to arms? Diabetes Care 2005; 28: 976-9
2. Pomposelli J, Baxter J, Babineau T, Pomfret E, Driscoll D, Forse R, Bistrian B: Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. J Parenter Enter Nutr1998. 22:77–81
3. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, and Kitabchi AE: Hyperglycemia: an
independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab.2002; 87:978–82
4. Bolk J, van der Ploeg T, Cornel JH, Arnold AE, Sepers J, Umans VA: Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 2001; 79:207–14
5. Alexiewicz J, Kumar D, Smogorzewski M, Klin M, Massry S: Polymorphonuclear leukocytes in noninsulin-dependent diabetes mellitus: abnormalities in metabolism and function. Ann Intern Med. 1995; 123:919–24
6. Sheetz M, King G: Molecular understanding of hyperglycemia’s adverse effects for diabetic
complications. JAMA 2002; 288:2579–88
7. Oldenborg P, Sehlin J: Hyperglycemia in vitro attenuates insulin-stimulated chemokinesis in normal human neutrophils: role of protein kinase C activation. J Leukocyte Biol 1999; 65:635–40
8. Liu BF, Miyata S, Kojima H, Uriuhara A, Kusunoki H, Suzuki K, Kasuga M: Low phagocytic activity of resident peritoneal macrophages in diabetic mice: relevance to the formation of advanced glycation end products. Diabetes 1999; 48:2074–82
9. Ortmeyer J, Mohsenin V: Inhibition of phospholipase D and superoxide generation by glucose in diabetic neutrophils. Life Sciences .1996; 59:255–62
10. Perner A, Nielsen S, Rask-Madsen J: High glucose impairs superoxide production from isolated blood neutrophils. Intensive Care Med 2003; 29:642–45
11. Sato N, Kashima K, Ohtani K, Shimizu H, Mori M: Epalrestat, an aldose reductase inhibitor, improves an impaired generation of oxygen-derived free radicals by neutrophils from poorly controlled NIDDM patients. Diabetes Care 1997; 20:995–98
12. Bouter KP, Meyling FH, Hoekstra JB, Masurel N, Erkelens DW, and Diepersloot RJ: Influence of blood glucose levels on peripheral lymphocytes in patients with diabetes mellitus. Diabetes Res 1992; 19:77–80
13. Kersten J, Schmeling T, Orth K, Pagel P, Warltier D: Acute hyperglycemia abolishes ischemic preconditioning in vivo. Am J Physiol 1998; 275:H721–25
14. Verma S, Maitland A, Weisel R, Li S, Fedak P, Pomroy N, Mickle D, Li R, Ko L, Rao V: Hyperglycemia exaggerates ischemia-reperfusion-induced cardiomyocyte injury: reversal with endothelin antagonism. J Thorac Cardiovasc Surg 2002; 123:1120–24
15. Ceriello A, Quagliaro L, D’Amico M, Di Filippo C, Marfella R, Nappo F, Berrino L, Rossi F, Giugliano D: Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 2002;51:1076–82
16. Marfella R, Nappo F, Angelis LD, Siniscalshi M, Rossi F, Giugliano D: The effect of acute
hyperglycaemia on QTc duration in healthy man. Diabetologia 2000;43:571–75
17. Pandolfi A, Giaccari A, Cilli C, Alberta M, Morviducci L, Filippis ED, Buongiorno A, Pellegrini G, Capani F, Consoli A: Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plaminogen activator inhibitor type 1 in the rat. Acta Diabetologica 2001; 38:71–7
18. Davi G, Catalano I, Averna M, Notarbartolo A, Strano A, Ciabattoni G, Patrono C: Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med 1990; 322:1769–74
19. Meldrum DR, Dinarello CA, Shames BD, Cleveland JC, Jr., Cain BS, Banerjee A, Meng X, Harken AH: Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor-alpha production: potential ultimate effector mechanism of preconditioning. Circulation 1998;II 214–I18
20. Tedgui A: Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001; 104:1598–1603
21. Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, Kugiyama K, Ogawa H, Yasue H: Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 1999; 34:146–54
21. Brodsky SV, Morrishow AM, Dharia N, Gross SS, Goligorsky MS: Glucose scavenging of nitric oxide. Am J Physiol Renal Physiol 2001; 280:F480–86
22. Pulsinelli WA, Waldman S, Rawlinson D, Plum F: Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology 1982; 32:1239-46
23. Hoxworth JM, Xu K, Zhou Y, Lust WD, LaManna JC: Cerebral metabolic profile, selective neuron loss, and survival of acute and chronic hyperglycemic rats following cardiac arrest and resuscitation. Brain 1999; Res 821:467–79
24. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994; 43:1271-78
25. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818–2
